1Khan SA,Taylor-Robinson SD,Toledano MB. Changing international trends in mortality rates for liver,biliary and pancreatic tumours[J].Hepatology,2002,(06):806-813.
2Shaib Y,E1,Scrag HB. The epidemiology of cholangiocarcinoma[J].Seminars in Liver Disease,2004,(02):115-125.
3Goepel C,Stoerer S,Koelbl H. Tenascin in preinvasive lesions of the vulva and vulvar cancer[J].Anticancer Research,2003,(6c):4587-4591.
4Brunner A,Mayerl C,Tzankov A. Prognostic significance of tenascin expression in superficial and invasive bladder cancer[J].Journal of Clinical Pathology,2004.927-931.
6Chen L,Yang S,Jakoncic J. Migrastatin analogues target fascin to block tumour metastasis[J].Nature,2010,(7291):1062-1066.
7Okada K,Shimura T,Asakawa K. Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer[J].Hepato-Gastroenterology,2007,(73):17-21.
8Iguchi T,Aishima S,Taketomi A. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma:immunohistocbemical and molecular analysis[J].Human Pathology,2009,(02):174-180.doi:10.1016/j.humpath.2008.06.029.
9Won KY,Kim GY,Lim SJ. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas[J].Pathol Res Praet,2009,(11):742-748.
3Yoon JH, Canbay AE, Werneburg NW, et al. Oxysterols induce eyelooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis[J].Hepatology, 2004,39(3) :732.
4Akihiko TA, Yuichi NW, Kazuhiko K, et al. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction[J]. Oncology Reports, 2003, (10) : 339.
5Kim HJ, Lee KT, Kim EK, et al. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis[J]. J Gastroenterol Hepatol, 2004,19(5) : 582.
6Chariyalertsak S, Sirikulchayanonta V, Mayer D, et al. Aberrant cyclooxygenase isoxyme expression in human intrahepatic cholangiocarcinoma [J]. Gut, 2001,48(1) :80.
7Wu GS, Wang JH, Liu ZR, et al. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcionoma[J]. Hepatobiliary Pancreat Dis Int, 2002, 1(3) :429.
8Wu T, Han C, Lunz JG, et al. Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells[J].Hepatology, 2002,36(2) :363.
9Han C, Leng J, Demetris AJ, et al. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21wafl/cipl and p27kipl and cell cycle arrest[J]. Cancer Res, 2004, 64(4) : 1 369.
10Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by Colon cancer cells[J]. Cell, 1998, 93:705.
